Guidelines for Blood Sampling Related to Research
FDA Guidance for Industry-Investigator Responsibilities-Protecting the Rights, Safety, and Welfare of Study Subjects
For all CMH Researchers: FYI - New Guidance for Investigators and Institutional Review Boards Regarding Research Involving Human Embryonic Stem Cells, Germ Cells, and Stem Cell-Derived Test Articles.
Of note are the comments regarding retention of personal identifiers on research samples and the effect on the need for IRB review. Please review at your convenience. Notice: NOT-OD-02-044
Kathy Johnson, RN, CCRC
Manager, Office for Research Integrity
|